Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Correction: Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer.

Gravina GL, Mancini A, Colapietro A, Marampon F, Sferra R, Pompili S, Biordi LA, Iorio R, Flati V, Argueta C, Landesman Y, Kauffman M, Shacham S, Festuccia C.

Oncotarget. 2019 Oct 29;10(59):6393-6395. doi: 10.18632/oncotarget.27289. eCollection 2019 Oct 29.

2.

The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models.

Gravina GL, Mancini A, Colapietro A, Delle Monache S, Sferra R, Pompili S, Vitale F, Martellucci S, Marampon F, Mattei V, Biordi L, Sherris D, Festuccia C.

Cancers (Basel). 2019 Oct 21;11(10). pii: E1604. doi: 10.3390/cancers11101604.

3.

Can Nrf2 Modulate the Development of Intestinal Fibrosis and Cancer in Inflammatory Bowel Disease?

Pompili S, Sferra R, Gaudio E, Viscido A, Frieri G, Vetuschi A, Latella G.

Int J Mol Sci. 2019 Aug 20;20(16). pii: E4061. doi: 10.3390/ijms20164061. Review.

4.

Carotid artery plaque characterization with a wide-detector computed tomography using a dedicated post-processing 3D analysis: comparison with histology.

Varrassi M, Sferra R, Gravina GL, Pompili S, Fidanza RC, Ventura M, Splendiani A, Barile A, Vetuschi A, Di Cesare E.

Radiol Med. 2019 Sep;124(9):795-803. doi: 10.1007/s11547-019-01026-8. Epub 2019 Mar 22.

PMID:
30903605
5.

The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models.

Gravina GL, Mancini A, Colapietro A, Delle Monache S, Sferra R, Vitale F, Cristiano L, Martellucci S, Marampon F, Mattei V, Beirinckx F, Pujuguet P, Saniere L, Lorenzon G, van der Aar E, Festuccia C.

Cancers (Basel). 2019 Mar 13;11(3). pii: E359. doi: 10.3390/cancers11030359.

6.

SIRT1 participates in the response to methylglyoxal-dependent glycative stress in mouse oocytes and ovary.

Di Emidio G, Santini SJ, D'Alessandro AM, Vetuschi A, Sferra R, Artini PG, Carta G, Falone S, Amicarelli F, Tatone C.

Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1389-1401. doi: 10.1016/j.bbadis.2019.02.011. Epub 2019 Feb 13.

PMID:
30771486
7.

Epidermal growth factor-like domain multiple 7 (EGFL7): Expression and possible effect on biliary epithelium growth in cholangiocarcinoma.

Mammola CL, Vetuschi A, Pannarale L, Sferra R, Mancinelli R.

Eur J Histochem. 2018 Nov 30;62(4). doi: 10.4081/ejh.2018.2971.

8.

Interaction between sphingosine kinase/sphingosine 1 phosphate and transforming growth factor-β/Smads pathways in experimental intestinal fibrosis. An in vivo immunohistochemical study.

Sferra R, Pompili S, Ventura L, Dubuquoy C, Speca S, Gaudio E, Latella G, Vetuschi A.

Eur J Histochem. 2018 Jul 31;62(3). doi: 10.4081/ejh.2018.2956.

9.

UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice.

Festuccia C, Gravina GL, Giorgio C, Mancini A, Pellegrini C, Colapietro A, Delle Monache S, Maturo MG, Sferra R, Chiodelli P, Rusnati M, Cantoni A, Castelli R, Vacondio F, Lodola A, Tognolini M.

Oncotarget. 2018 May 11;9(36):24347-24363. doi: 10.18632/oncotarget.25272. eCollection 2018 May 11.

10.

Immunolocalization of Advanced Glycation End Products, Mitogen Activated Protein Kinases, and Transforming Growth Factor-β/Smads in Pelvic Organ Prolapse.

Vetuschi A, Pompili S, Gallone A, D'Alfonso A, Carbone MG, Carta G, Festuccia C, Gaudio E, Colapietro A, Sferra R.

J Histochem Cytochem. 2018 Sep;66(9):673-686. doi: 10.1369/0022155418772798. Epub 2018 May 8.

11.

Episode-like pulse testosterone supplementation induces tumor senescence and growth arrest down-modulating androgen receptor through modulation of p-ERK1/2, pARser81 and CDK1 signaling: biological implications for men treated with testosterone replacement therapy.

Gravina GL, Marampon F, Sanità P, Festuccia C, Forcella C, Scarsella L, Jitariuc A, Vetuschi A, Sferra R, Colapietro A, Carosa E, Dolci S, Lenzi A, Jannini EA.

Oncotarget. 2017 Nov 30;8(69):113792-113806. doi: 10.18632/oncotarget.22776. eCollection 2017 Dec 26.

12.

Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer.

Gravina GL, Mancini A, Colapietro A, Marampon F, Sferra R, Pompili S, Biordi LA, Iorio R, Flati V, Argueta C, Landesman Y, Kauffman M, Shacham S, Festuccia C.

Oncotarget. 2017 Nov 30;8(67):111225-111245. doi: 10.18632/oncotarget.22760. eCollection 2017 Dec 19. Erratum in: Oncotarget. 2019 Oct 29;10(59):6393-6395.

13.

The Natural Carotenoid Crocetin and the Synthetic Tellurium Compound AS101 Protect the Ovary against Cyclophosphamide by Modulating SIRT1 and Mitochondrial Markers.

Di Emidio G, Rossi G, Bonomo I, Alonso GL, Sferra R, Vetuschi A, Artini PG, Provenzani A, Falone S, Carta G, D'Alessandro AM, Amicarelli F, Tatone C.

Oxid Med Cell Longev. 2017;2017:8928604. doi: 10.1155/2017/8928604. Epub 2017 Nov 15.

14.

Development of hepatocellular cancer induced by long term low fat-high carbohydrate diet in a NAFLD/NASH mouse model.

Tessitore A, Mastroiaco V, Vetuschi A, Sferra R, Pompili S, Cicciarelli G, Barnabei R, Capece D, Zazzeroni F, Capalbo C, Alesse E.

Oncotarget. 2017 Jun 21;8(32):53482-53494. doi: 10.18632/oncotarget.18585. eCollection 2017 Aug 8.

15.

The possible prognostic role of histone deacetylase and transforming growth factor β/Smad signaling in high grade gliomas treated by radio-chemotherapy: a preliminary immunohistochemical study.

Sferra R, Pompili S, Festuccia C, Marampon F, Gravina GL, Ventura L, Di Cesare E, Cicchinelli S, Gaudio E, Vetuschi A.

Eur J Histochem. 2017 May 16;61(2):2732. doi: 10.4081/ejh.2017.2732.

16.

HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells.

Marampon F, Megiorni F, Camero S, Crescioli C, McDowell HP, Sferra R, Vetuschi A, Pompili S, Ventura L, De Felice F, Tombolini V, Dominici C, Maggio R, Festuccia C, Gravina GL.

Cancer Lett. 2017 Jul 1;397:1-11. doi: 10.1016/j.canlet.2017.03.028. Epub 2017 Mar 23.

PMID:
28342984
17.

Role of glycogen synthase kinase-3β and PPAR-γ on epithelial-to-mesenchymal transition in DSS-induced colorectal fibrosis.

Di Gregorio J, Sferra R, Speca S, Vetuschi A, Dubuquoy C, Desreumaux P, Pompili S, Cristiano L, Gaudio E, Flati V, Latella G.

PLoS One. 2017 Feb 16;12(2):e0171093. doi: 10.1371/journal.pone.0171093. eCollection 2017.

18.

The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma.

Gravina GL, Mancini A, Marampon F, Colapietro A, Delle Monache S, Sferra R, Vitale F, Richardson PJ, Patient L, Burbidge S, Festuccia C.

J Hematol Oncol. 2017 Jan 5;10(1):5. doi: 10.1186/s13045-016-0377-8.

19.

Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage.

Marampon F, Gravina GL, Ju X, Vetuschi A, Sferra R, Casimiro MC, Pompili S, Festuccia C, Colapietro A, Gaudio E, Di Cesare E, Tombolini V, Pestell RG.

Oncotarget. 2016 Sep 27;7(39):64526. doi: 10.18632/oncotarget.12267. No abstract available.

20.

Expression of pro-fibrotic and anti-fibrotic molecules in dimethylnitrosamine-induced hepatic fibrosis.

Sferra R, Vetuschi A, Pompili S, Gaudio E, Speca S, Latella G.

Pathol Res Pract. 2017 Jan;213(1):58-65. doi: 10.1016/j.prp.2016.11.004. Epub 2016 Nov 11.

PMID:
27894619

Supplemental Content

Loading ...
Support Center